piracetam and dm 235
piracetam has been researched along with dm 235 in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bartolini, A; Dei, S; Galeotti, N; Ghelardini, C; Gualtieri, F; Guandalini, L; Manetti, D; Martini, E; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Dei, S; Ghelardini, C; Guandalini, L; Manetti, D; Martini, E; Melchiorre, M; Norcini, M; Pagella, S; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Cellai, C; Dei, S; Ghelardini, C; Guandalini, L; Manetti, D; Martelli, C; Martini, E; Melchiorre, M; Romanelli, MN; Salvicchi, A; Scapecchi, S; Teodori, E | 1 |
| Dei, S; Di Cesare Mannelli, L; Ghelardini, C; Guandalini, L; Manetti, D; Martini, E; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Bartolucci, G; Dei, S; Di Cesare Mannelli, L; Floriddia, E; Ghelardini, C; Guandalini, L; Malik, R; Manetti, D; Martino, MV; Melani, F; Orlandi, F; Romanelli, MN; Teodori, E | 1 |
| Bartolucci, G; Dei, S; Di Cesare Mannelli, L; Ghelardini, C; Guandalini, L; Manetti, D; Martino, MV; Menicatti, M; Romanelli, MN; Teodori, E | 1 |
Other Studies
7 other study(ies) available for piracetam and dm 235
| Article | Year |
|---|---|
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs.
Topics: Amnesia; Animals; Avoidance Learning; Chemical Phenomena; Chemistry, Physical; Cognition; Dose-Response Relationship, Drug; Indicators and Reagents; Mice; Muscarinic Antagonists; Neurodegenerative Diseases; Nootropic Agents; Piperidines; Receptors, AMPA; Scopolamine; Structure-Activity Relationship | 2003 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Topics: Animals; Avoidance Learning; Data Interpretation, Statistical; Drug Design; Mice; Nootropic Agents; Piperazines; Pyrroles; Recognition, Psychology | 2008 |
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.
Topics: Animals; Cognition; Disease Models, Animal; Drug Design; Mice; Nootropic Agents; Piperazines; Sulfonamides | 2009 |
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs.
Topics: Adjuvants, Anesthesia; Amnesia; Animals; Avoidance Learning; Cognition; Drug Design; Mice; Nootropic Agents; Piperazines; Scopolamine; Structure-Activity Relationship; Sulfonamides | 2012 |
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Topics: Amnesia; Animals; Avoidance Learning; Mice; Nootropic Agents; Piperazines; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2015 |
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.
Topics: Animals; Avoidance Learning; Carbon-13 Magnetic Resonance Spectroscopy; Cognition; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Mice; Nootropic Agents; Piperazines; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization | 2017 |